Novartis | NOVN - Capital Ordinaire

Prix De L'Action
113.70
Variation Quotidienne
-2.58 -2.22%
Mensuellement
-4.95%
Annuel
22.87%
Q2 Prévisions
111.47




Capital Ordinaire Changement Date
AbbVie USD 1.77B 1.75B 2025-06
Alcon AG USD 487.4M 7.2M 2025-12
Almirall EUR 214.79M 0 2025-12
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Autolus Therapeutics Ltd USD 266.14M 1.88K 2025-09
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Fresenius EUR 563.24M 0 2025-09
Fresenius Medical Care EUR 279.29M 10.56M 2025-12
Galapagos EUR 65.9M 0 2025-12
Genmab DKK 61.62M 52K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
J&J USD 2.41B 1.74M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2025-12
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Novo Nordisk DKK 4.44B 0 2025-12
Orion EUR 140.87M 173K 2026-03
Pfizer USD 5.69B 1000K 2025-09
Philips EUR 951.29M 310K 2025-12
Recordati EUR 205.83M 270K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12